This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

IMAAVY™ (nipocalimab-aahu)

Medical Information

IMAAVY – Effect on Fertility in Patients with Generalized Myasthenia Gravis

Last Updated: 05/02/2025

SUMMARY

  • The company cannot recommend any practices, procedures, or usage that deviate from the approved labeling.
  • Please refer to the local labeling for relevant fertility-related information for IMAAVY.
  • There are no relevant data available regarding the effects of IMAAVY on fertility in humans. Animal studies do not indicate harmful effects with respect to fertility.1 

Literature Search

A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, DERWENT® (and/or other resources, including internal/external databases) conducted on 24 February 2025 did not identify any relevant citations pertaining to this topic.

References

1 Data on File. Nipocalimab Company Core Data Sheet v002. Janssen Research & Development, LLC. EDMS-RIM-1007434; 2024.